Skip to main content
. 2014 Jun 27;9(6):e100981. doi: 10.1371/journal.pone.0100981

Figure 2. Kaplan-Meier survival curves of RSV hospitalization rate stratified by palivizumab treatment.

Figure 2

There was statistically significant difference between palivizumab and control group (p = 0.001, log-rank test).